AbbVie Stock Creeps Toward 52-Week High as Shares Trade at $296.98

By TrendSpider Editor

ABBV market update based on latest price_mover data.

AbbVie Stock Creeps Toward 52-Week High as Shares Trade at $296.98

AbbVie Inc. shares gained 0.62% on Monday, November 16, 2026, pushing the stock to $296.98 and within striking distance of its 52-week high of $302.93. The move comes after a session in which shares touched an intraday high of $297.25, suggesting buyers are maintaining pressure near the top of the stock's annual range. With a 52-week low of $191.00, ABBV has staged an impressive run, and the market is now watching closely to see whether the stock can break through to new highs.

Key Drivers of the ABBV Stock Move

The setup heading into the week is one of constructive consolidation near a technically significant level. ABBV has covered substantial ground from its 52-week low of $191.00, representing a move of more than 100 points over the past year. The critical question for traders is whether the stock can sustain the energy needed to clear $302.93 and establish a new range. The intraday action on Monday, where shares briefly touched $297.25 before pulling back modestly to close at $296.98, reflects a market that is cautious but not bearish at current levels. Volume and momentum indicators will be key in determining whether this consolidation resolves to the upside or stalls.

ABBV Seasonality

Mid-November historically represents the beginning of a period when large-cap pharmaceutical and biotech names benefit from year-end portfolio repositioning, as institutional investors look to lock in exposure to defensive healthcare stocks ahead of the new year. For a stock already trading near annual highs, this seasonal tailwind could add incremental support.

ABBV Relative Performance

ABBV's gain of 0.62% on Monday positions it as a steady performer within the large-cap pharmaceutical space. Trading at $296.98 against a 52-week range of $191.00 to $302.93, the stock is operating in the top tier of its annual range, reflecting relative strength compared to broader healthcare sector peers that have faced more volatility in recent months. The stock's ability to hold ground near multi-year highs while the broader market navigates macroeconomic uncertainty underscores its defensive appeal among investors seeking stability with growth potential.

More on ABBV

Latest Market News